#United States #Asheville #LevEllis #PROVOQUE #Renee Pedroza

LevEllis™ Strengthens Leadership Team for Growth

Major Leadership Appointments

On October 8, 2026, LevEllis, Inc., a pioneering biotechnology firm known for its innovative product PROVOQUE™, announced two significant additions to its executive team. Renee Romero Pedroza has been appointed as Chief Marketing Officer (CMO), while Wendy Patrick takes on the role of Vice President of Sales. These appointments are part of LevEllis' strategy to enhance its commercial capabilities and advance its position in both professional skincare and regenerative biology.

Building the Future of Aesthetics

The new executives come with extensive backgrounds in aesthetics and strategic marketing. Renee Pedroza joins LevEllis after a successful 14-year tenure at ZO Skin Health, where she played a crucial role in elevating the brand into a leader in physician-dispensed skincare. As CMO, she will be key in developing LevEllis' commercial strategies, overseeing aspects from marketing to product development for PROVOQUE.

Pedroza expressed her enthusiasm, stating, "What drew me to LevEllis was more than a new product. It was a fundamentally different approach to skin and Dr. Ellis' vision for advancing regenerative skin health."

Wendy Patrick brings over 20 years of experience in medical aesthetics and is well-known for her previous leadership roles at ALASTIN Skincare. As VP of Sales, she will focus on national sales strategy, revenue planning, and strengthening partnerships within the aesthetic community. Patrick emphasized the importance of education in her approach: "Twenty years in this industry has taught me that science earns a provider's attention, but education earns their trust."

The Science Behind PROVOQUE

LevEllis is dedicated to revolutionizing skincare through its proprietary platform, which combines the principles of regenerative biology with a focus on skin longevity. The goal is to create products that serve the skin at a biological level, treating it as a complex system rather than isolated parts. Their flagship product, PROVOQUE Facial Serum, exemplifies this approach by using a complete skin-specific secretome derived from skin progenitor cells.

Laura Ellis, MD, the founder and CEO, stated, "Our science is rooted in regenerative biology and in a simple but important principle: skin functions as a coordinated biological system. No single signal operates in isolation."

Emphasizing a Comprehensive Approach

Both Pedroza and Patrick will leverage their skills to ensure that LevEllis captures the full potential of its scientific discoveries in the market. Their strategy will encompass enhancing customer experience through education, building provider trust, and ultimately changing perceptions surrounding aging and skin health.

Shannon Crothers, the Chief Operating Officer, remarked, "Renee and Wendy bring complementary strengths to LevEllis. We have an extraordinary platform and an opportunity to build an exceptional company around it, focusing on our providers and their patients."

Looking Ahead

As LevEllis embarks on this new chapter in its journey, the company is poised for growth at the intersection of scientific innovation and practical application in the world of aesthetics. For more information about PROVOQUE and LevEllis, visit www.myprovoque.com.

The advancements in their leadership structure are expected to facilitate further discoveries in regenerative skincare, making LevEllis a key player in the biotechnology landscape of the future.